Company Corbus Pharmaceuticals Holdings, Inc.
Equities
CRBP
US21833P3010
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.13 USD | -5.30% | +3.11% | +630.63% |
Jun. 03 | Corbus Pharmaceuticals Reaches 2-Year High After Drug Results | DJ |
Jun. 03 | Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $80 From $60, Maintains Outperform Rating | MT |
Business Summary
Number of employees: 19
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yuval Cohen
CEO | Chief Executive Officer | 49 | 13-06-30 |
Sean Moran
DFI | Director of Finance/CFO | 66 | 14-04-10 |
Chief Tech/Sci/R&D Officer | 50 | Feb. 27 | |
Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Holmer
CHM | Chairman | 74 | 13-12-31 |
Avery Catlin
BRD | Director/Board Member | 75 | 14-07-31 |
Yuval Cohen
CEO | Chief Executive Officer | 49 | 13-06-30 |
John Jenkins
BRD | Director/Board Member | 66 | 18-06-04 |
Jacques Suzanne
BRD | Director/Board Member | 53 | 19-04-07 |
Yong Ben
BRD | Director/Board Member | 50 | 23-02-28 |
Peter Salzmann
BRD | Director/Board Member | 56 | 20-03-05 |
Anne Altmeyer
BRD | Director/Board Member | 59 | 22-09-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,686,693 | 10,594,451 ( 99.14 %) | 0 | 99.14 % |
Company contact information
Corbus Pharmaceuticals Holdings, Inc.
500 River Ridge Drive Second floor
02062, Norwood
+617 963 0100
http://www.corbuspharma.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+630.63% | 472M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- CRBP Stock
- Company Corbus Pharmaceuticals Holdings, Inc.